Pursuant to Regulation 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, SEBI Circular No. SEBI/HO/CFD/CFD- PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE Circular No. 20250102- 4 and NSE Circular No. NSE/CML/2025/02 dated January 2, 2025, Kronox Lab Sciences has enclosed the Integrated Filing (Financial) including the unaudited standalone financial results of the Company for the quarter and nine- months ended December 31, 2024 (Results), along with Limited Review Reports of the Statutory Auditors. The Results are being uploaded on the website of the Company and will also be published in the newspapers. The Meeting of Board of Directors commenced at 3:30 pm and concluded at 4.30 pm.
The above information is a part of company’s filings submitted to BSE.
